LPS-activated monocytes suppress T-cell immune responses and induce FOXP3+ T cells through a COX-2-PGE2-dependent mechanism

International Immunology

Volumn 20, Issue 2, 2008, Pages 235-245

  Bryn, Tone ^a,c   Yaqub, Sheraz ^a   Mahic, Milada ^a   Henjum, Karen ^a,b   Aandahl, Einar M ^a   Tasén, Kjetil ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^c ASTRAZENECA   (United Kingdom)

Author keywords

COX 2; FOXP3; Human; LPS; Monocytes; PGE2

Indexed keywords

CYCLIC AMP; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; HUMORAL ANTIBODY; LIPOPOLYSACCHARIDE; NEUTRALIZING ANTIBODY; PROSTAGLANDIN E2; TRANSCRIPTION FACTOR FOXP3;

ANTIBODY PRODUCTION; ANTIGEN PRESENTATION; ANTIGEN SPECIFICITY; ARTICLE; CELL INTERACTION; CELLULAR IMMUNITY; CONTROLLED STUDY; EFFECTOR CELL; HUMAN; HUMAN CELL; INNATE IMMUNITY; MONOCYTE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE;

CD4-POSITIVE T-LYMPHOCYTES; CELL COMMUNICATION; CYCLOOXYGENASE 2; CYTOKINES; DINOPROSTONE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LIPOPOLYSACCHARIDES; LYMPHOCYTE ACTIVATION; MONOCYTES; T-LYMPHOCYTES;

EID: 39049131312     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxm134     Document Type: Article

References (47)

1. Akira, S. and Takeda, K. 2004. Toll-like receptor signalling. Nat. Rev. Immunol. 4:499.
2. Yaqub, S., Solhaug, V., Vang, T. et al. 2003. A human whole blood model of LPS-mediated suppression of T cell activation. Med. Sci. Monit. 9:BR120.
3. Haupt, W., Fritzsche, H., Hohenberger, W. and Zirngibl, H. 1996. Selective cytokine release induced by serum and separated plasma from septic patients. Eur. J. Surg. 162:769.
4. Astiz, M., Saha, D., Lustbader, D., Lin, R. and Rackow, E. 1996 Monocyte response to bacterial toxins, expression of cell surface receptors, and release of anti-inflammatory cytokines during sepsis. J. Lab. Clin. Med. 128:594.
5. Annane, D., Bellissant, E. and Cavaillon, J. M. 2005. Septic shock. Lancet 365:63.
6. Harris, S. G., Padilla, J., Koumas, L., Ray, D. and Phipps, R. P. 2002. Prostaglandins as modulators of immunity. Trends Immunol. 23:144.
7. Dubois, R. N., Abramson, S. B., Crofford, L. et al. 1998. Cyclooxygenase in biology and disease. FASEB J. 12:1063.
8. Feng, L., Xia, Y., Garcia, G. E., Hwang, D. and Wilson, C. B. 1995. Involvement of reactive oxygen intermediates in cyclooxygenase-2 expression induced by interleukin-1, tumor necrosis factor-alpha, and lipopolysaccharide. J. Clin. Invest. 95:1669.
9. Hinz, B., Brune, K. and Pahl, A. 2000. Cyclooxygenase-2 expression in lipopolysaccharide-stimulated human monocytes is modulated by cyclic AMP, prostaglandin E(2), and nonsteroidal anti-inflammatory drugs. Biochem. Biophys. Res. Commun. 278:790.
10. Kurland, J. I. and Bockman, R. 1978. Prostaglandin E production by human blood monocytes and mouse peritoneal macrophages. J. Exp. Med. 147:952.
11. Breyer, R. M., Bagdassarian, C. K., Myers, S. A. and Breyer, M. D. 2001. Prostanoid receptors: Subtypes and signaling. Annu. Rev Pharmacol. Toxicol. 41:661.
12. Meja, K. K., Barnes, P. J. and Giembycz, M. A. 1997. Characterization of the prostanoid receptor(s) on human blood monocytes at which prostaglandin E2 inhibits lipopolysaccharide-induced tumour necrosis factor-alpha generation. Br. J. Pharmacol. 122:149.
13. Torgersen, K. M., Vang, T, Abrahamsen, H., Yaqub, S. and Tasken, K. 2002. Molecular mechanisms for protein kinase A-mediated modulation of immune function. Cell Signal. 14:1.
14. Lohr, J., Knoechel, B. and Abbas, A. K. 2006. Regulatory T cells in the periphery. Immunol. Rev. 212:149.
15. Chen, W. 2006. Dendritic cells and (CD4+)CD25+ T regulatory cells: crosstalk between two professionals in immunity versus tolerance. Front. Biosci. 11:1360.
16. Azuma, T., Takahashi, T., Kunisato, A., Kitamura, T. and Hirai H. 2003. Human CD4+ CD25+ regulatory T cells suppress NKT cell functions. Cancer Res. 63:4516.
17. Lim, H. W., Hillsamer, P., Banham, A. H. and Kim, C. H. 2005. Cutting edge: Direct suppression of B cells by CD4+ CD25+ regulatory T cells. J. Immunol. 175:4180.
18. Trzonkowski, P., Szmit, E., Mysliwska, J., Dobyszuk, A. and Mysliwski, A. 2004. CD4+-CD25+ T regulatory cells inhibit cytotoxic activity of T CD8+ anal NK lymphocytes in the direct cell-to-cell interaction. Clin Immunol. 112:258.
19. Murakami, M., Sakamoto, A., Bender, J., Kappler, J. and Marrack, P. 2002: CD25+CD4+ T cells contribute to the control of memory CD8+ T cells. Proc. Natl Acad. Sci. USA 99:8832.
20. Taams, L. S., van Amelsfort, J. M., Tiemessen, M. M. et al. 2005. Modulation of monocyte/macrophage function by human CD4+CD25+ regulatory T cells. Hum. Immunol. 66:222.
21. Walker, M. R., Kasprowicz, D. J., Gersuk, V. H. et al. 2003. Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+. J. Clin. Invest. 112:1437.
22. Kretschmer, K., Apostolou, I., Hawiger, D., Khazaie, K., Nussenzweig, M. C. and von, B.H. 2005. Inducing and expanding regulatory T cell populations by foreign antigen. Nat Immunol. 6:1219.
23. Mahic, M., Yaqub, S., Johansson, C. C., Tasken, K. and Aandahl, E. M. 2006. FOXP3+CD4+CD25+ adaptive regulatory T cells express cyclooxygenase-2 and suppress effector T cells by a prostaglandin E2-dependent mechanism. J. Immunol. 177:246.
24. Baratelli, F., Lin, Y., Zhu, L. et al. 2005. Prostaglandin E2 induces FOXP3 gene expression and T regulatory cell function in human CD4+ T cells. J. Immunol. 175:1483.
25. Sharma, S., Yang, S. C., Zhu, L. et al. 2005. Tumor cyclooxygenase-2/prostaglandin E2-dependent promotion of FOXP3 expression and CD4+ CD25+ T regulatory cell activities in lung cancer. Cancer Res. 65:5211.
26. Maloy, K. J., Salaun,.L., Cahill, R., Dougan, G., Saunders, N. J. and Powrie, F. 2003. CD4+CD25+ T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms. J. Exp. Med. 197:111.
27. Wan, Y. Y. and Flavell, R. A. 2006. The roles for cytokines in the generation and maintenance of regulatory T cells. Immunol. Rev. 212:114.
28. Fantini, M. C., Becker, C., Monteleone, G., Pallone, F., Galle, P. R. and Neurath, M. F. 2004. Cutting edge: TGF-beta induces a regulatory phenotype in CD4+. J. Immunol. 172:5149.
29. Chen, W., Jin, W., Hardegeg, N. et al. 2003. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J. Exp. Med. 198:1875.
30. Mnich, S. J., Veenhuizen, A. W., Monahan, J. B. et al. 1995. Characterization of a monoclonal antibody that neutralizes the activity of prostaglandin E2. J. Immunol. 155:4437.
31. Monneret, G., Debard, A. L., Venet, F. et al. 2003. Marked elevation of human circulating CD4+CD25+ regulatory T cells in sepsis-induced immunoparalysis. Crit. Care Med. 31: 2068.
32. Monneret, G., Lepape, A., Voirin, N. et al. 2006. Persisting low monocyte human leukocyte antigen-DR expression predicts mortality in septic shock. Intensive Care Med 32:1175.
33. Heidecke, C. D., Hensler, T., Weighardt, H. et al. 1999. Selective defects of T lymphocyte function in patients with lethal intra-abdominal infection. Am. J. Surg. 178:288.
34. Osuchowski, M. F., Welch, K., Siddiqui, J. and Remick, D. G. 2006. Circulating cytokine/inhibitor profiles reshape the understanding of the SIRS/CARS continuum in sepsis and predict mortality. J. Immunol. 177:1967.
35. Reddy, R. C., Chen, G. H., Tekchandani, P. K. and Standiford, T. J. 2001. Sepsis-induced immunosuppression: From bad to worse. Immunol. Res. 24:273.
36. Venet, F., Pachot, A., Debard, A. L. et al. 2006. Human CD4+CD25+ regulatory T lymphocytes inhibit lipopolysaccharide-induced monocyte survival through a Fas/Fas ligand-dependent mechanism. J. Immunol. 177:6540.
37. Pasare, C. and Medzhitov, R. 2004, Toll-dependent control mechanisms of CD4 T cell activation. Immunity 21:733.
38. Pasare, C, and Medzhitov R. 2003. Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science 299:1033.
39. Caramalho, I., Lopes-Carvalho, T., Ostler, D., Zelenay, S., Haury, M, and Demengeot, J. 2003. Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide. J. Exp. Med. 197:403.
40. Netea, M.. G., Sutmuller, R., Hermann, C. et al. 2004. Toll-like receptor 2 suppresses immunity against Candida albicans through induction of IL-10 and regulatory T cells. J. Immunol. 172:3712.
41. Komai-Koma, M., Jones, L., Ogg, G. S., Xu, D. and Liew, F. Y. 2004. TLR2 is expressed on activated T cells as a costimulatory receptor. Proc. Natl Acad Sci. USA 101:3029.
42. Liu, H., Komai-Koma, M., Xu, D. and Liew, F. Y. 2006. Toll-like receptor 2 signaling modulates the functions of CD4+ CID25+ regulatory T cells. Proc. Natl Acad. Sci. USA 103:7048.
43. Poltorak, A., He, X., Smimova, I. et al. 1998. Defective LIPS signaling in C3H/HeJ and C57BL/10ScCr mice: Mutations in TIr4 gene. Science 282:2085.
44. Tough, D. F., Sun, S. and Sprent, J. 1997. T cell stimulation in vivo by lipopolysaccharide (LPS). J. Exp. Med. 185:2089.
45. Venet, F., Pachot, A.; Debard, A. L. et al. 2004. Increased percentage of CD4+CD25+ regulatory T cells during septic shock is due to the decrease of CD4+. Crit. Care Med. 32:2329.
46. von Boehmer, H. 2005. Mechanisms of suppression by suppressor T cells. Nat. Immunol. 6:338.
47. Rutella, S., Danese, S. and Leone, G. 2006. Tolerogenic dendritic cells: cytokine modulation comes of age. Blood 108:1435.